We are live on ! Find out more

379 hedge funds and large institutions have $2.2B invested in Chemours in 2016 Q3 according to their latest regulatory filings, with 53 funds opening new positions, 87 increasing their positions, 134 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

233% more funds holding in top 10

Funds holding in top 10: 310 (+7)

89% more capital invested

Capital invested by funds: $1.16B → $2.2B (+$1.04B)

75% more call options, than puts

Call options by funds: $32.8M | Put options by funds: $18.8M

26% more first-time investments, than exits

New positions opened: 53 | Existing positions closed: 42

2% more funds holding

Funds holding: 372379 (+7)

1.76% less ownership

Funds ownership: 77.86%76.1% (-1.8%)

35% less repeat investments, than reductions

Existing positions increased: 87 | Existing positions reduced: 134

Holders
379
Holders Change
+7
Holders Change %
+1.88%
% of All Funds
10.08%
Holding in Top 10
10
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+233.33%
% of All Funds
0.27%
New
53
Increased
87
Reduced
134
Closed
42
Calls
$32.8M
Puts
$18.8M
Net Calls
+$14M
Net Calls Change
+$16.2M

CC Hedge Fund Activity: Q3 2016 in Review

379 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q3 2016, worth a combined $2.2B — up 89% from $1.16B a quarter earlier.

Buyers outnumbered sellers: 53 funds opened new CC positions and 42 closed out — a net gain of 11 holders — while 87 added to existing stakes and 134 trimmed.

The largest buyer was Systematic Financial Management, opening a new position worth an estimated $34.8M. The largest seller was Capital Research Global Investors, exiting entirely with an estimated $39.1M sold.

  • 379 institutional investors held Chemours (CC) as of Q3 2016, up from 372 in Q2 2016.
  • Funds reported $2.2B of Chemours stock for Q3 2016, up 89% quarter-over-quarter.
  • 53 funds opened new Chemours positions in Q3 2016 and 42 closed out, a net change of +11 holders.
  • The largest Chemours buyer in Q3 2016 was Systematic Financial Management, an estimated $34.8M added.
  • The largest Chemours seller in Q3 2016 was Capital Research Global Investors, an estimated $39.1M sold.

Based on aggregated 13F filings for Q3 2016.